RESOLVYX PHARMACEUTICALS INC has a total of 44 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are MEDISYN TECHNOLOGIES INC, VERLYX PHARMA INC and OLATEC THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Australia | 5 | |
#5 | Canada | 4 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 | |
#13 | Taiwan | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Gjorstrup Per | 40 |
#2 | Schwartz C Eric | 12 |
#3 | Qin Shixin | 4 |
#4 | Wu Lijun | 4 |
#5 | Nichols Matthew James | 3 |
#6 | Per Gjorstrup | 2 |
#7 | Schwartz Eric | 1 |
#8 | Eric Schwartz C | 1 |
Publication | Filing date | Title |
---|---|---|
AU2014201375A1 | Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions | |
TW201039815A | Compositions and methods for the treatment of inflammation | |
WO2010091226A1 | Compositions and methods for organ preservation | |
WO2010039529A2 | Compositions and methods for the treament of inflammatory disease | |
WO2010039531A1 | Therapeutic compounds | |
KR20150115959A | Oxylipin compounds for the treatment of ophthalmic conditions | |
AU2008301895A1 | Oxylipin compounds for treating autoimmune diseases | |
US2008161275A1 | Compositions and methods for the treatment of inflammatory disease | |
EP2131833A2 | Use of resolvins for inhibition of bone loss | |
EP2049099A1 | Compositions and methods for the treatment of mucositis | |
EP2012828A2 | Compositions and methods for the treatment of cardiovascular disease |